Stigliani, Sara
Amaro, Adriana
Reggiani, Francesco
Maccarini, Elena
Massarotti, Claudia
Lambertini, Matteo
Anserini, Paola
Scaruffi, Paola
Article History
Received: 1 May 2024
Accepted: 1 July 2024
First Online: 17 September 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethical Committee of Regione Liguria (protocol code 1149, June 10th, 2021).
: Not applicable.
: M.L. reports advisory role for Roche, Lilly, Novartis, Astrazeneca, Pfizer, Seagen, Gil-ead, MSD and Exact Sciences and speaker honoraria from Roche, Lilly, Novartis, Pfizer, Sandoz, Libbs, Daiichi Sankyo, Knight and Takeda, Travel Grants from Gilead and Daiichi Sankyo, and research support (to the Institution) from Gilead outside the submitted work. P.A. reports speaker honoraria from Gedeon Richter, Merck and Organon outside the submitted work. The other authors declare no conflict of interest.